Petitioner Urges Board To Cancel Patented DNA Sequencing Method

(April 12, 2022, 12:15 PM EDT) -- ALEXANDRIA, Va. — In an April 8 petition for inter partes review (IPR) filed with the Patent Trial and Appeal Board, a cancer diagnostics company takes aim at a University of...
To view the full article, register now.